OTCPK:SRUP

Stock Analysis Report

Executive Summary

Sirrus Corp. provides cyber security services primarily for the healthcare industry in the United States.

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.

Risks

  • Sirrus has significant price volatility in the past 3 months.
  • Sirrus's last earnings update was 430 days ago.
  • Sirrus is not covered by any analysts.

Similar Companies

Share Price & News

How has Sirrus's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

4900.0%

SRUP

0.9%

US Healthcare Services

-0.2%

US Market


1 Year Return

-83.3%

SRUP

8.7%

US Healthcare Services

1.1%

US Market

SRUP underperformed the Healthcare Services industry which returned 8.6% over the past year.

SRUP underperformed the Market in United States of America which returned 1.6% over the past year.


Share holder returns

SRUPIndustryMarket
7 Day4900.0%0.9%-0.2%
30 Day-50.0%-5.2%2.5%
90 Day-50.0%-5.5%1.6%
1 Year-83.3%-83.3%8.8%8.7%3.4%1.1%
3 Yearn/a49.7%49.4%45.2%35.8%
5 Yearn/a50.3%49.4%62.6%44.8%

Price Volatility Vs. Market

How volatile is Sirrus's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Sirrus undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Sirrus is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Sirrus has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of SRUP’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Sirrus regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Sirrus expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

27.6%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sirrus has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of SRUP’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Sirrus's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Sirrus performed over the past 5 years?

-363.7%

Last years earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Sirrus does not make a profit and there is insufficient past data to establish if their 5 year on year earnings growth rate was positive.

Unable to compare Sirrus's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Sirrus's 1-year growth to the US Healthcare Services industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Sirrus has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if Sirrus has efficiently used its assets last year compared to the US Healthcare Services industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Sirrus improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is Sirrus's financial position?


Financial Position Analysis

Sirrus's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Sirrus has no long term commitments.


Debt to Equity History and Analysis

Sirrus has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if Sirrus's debt level has increased considering it has negative shareholder equity.

Operating cash flow is negative therefore debt is not well covered.

Unable to confirm if the interest payments on Sirrus's debt are well covered by earnings due to lack of past financial data.


Balance Sheet

Low level of unsold assets.

Sirrus has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Next Steps

Dividend

What is Sirrus's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Sirrus's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Sirrus's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Sirrus has not reported any payouts.

Unable to verify if Sirrus's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Sirrus has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Sirrus's salary, the management and board of directors tenure and is there insider trading?

2.9yrs

Average management tenure


CEO

Sparrow Marcioni (62yo)

2.9yrs

Tenure

US$105,000

Compensation

Ms. Sparrow Marcioni has been the Chief Executive Officer, President, Secretary, Treasurer and Director of Sirrus Corp. since October 14, 2016 and serves as its Principal Accounting Officer. Ms. Marcioni h ...


Management Age and Tenure

2.9yrs

Average Tenure

The tenure for the Sirrus management team is about average.


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • Sparrow Marcioni (62yo)

    President

    • Tenure: 2.9yrs
    • Compensation: US$105.00k
  • Steven James (53yo)

    Chief Technology Officer

    • Tenure: 2.9yrs
  • Kim Carter

    Vice President of Sales & Finance

    • Tenure: 1.5yrs

Board Members

  • Sparrow Marcioni (62yo)

    President

    • Tenure: 2.9yrs
    • Compensation: US$105.00k

Company Information

Sirrus Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Sirrus Corp.
  • Ticker: SRUP
  • Exchange: OTCPK
  • Founded: 2014
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: US$58.316k
  • Shares outstanding: 1.17b
  • Website: https://www.sirrussecurity.com

Location

  • Sirrus Corp.
  • 11340 Lakefield drive
  • Suite 200
  • Johns Creek
  • Georgia
  • 30097
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SRUPOTCPK (Pink Sheets LLC)YesCommon StockUSUSDSep 2015

Biography

Sirrus Corp. provides cyber security services primarily for the healthcare industry in the United States. The company offers security technology products and services to help companies protect their assets ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/20 01:13
End of Day Share Price2019/09/19 00:00
Earnings2018/05/31
Annual Earnings2017/08/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.